ID   IKKA_HUMAN              Reviewed;         745 AA.
AC   O15111; O14666; Q13132; Q5W0I4; Q92467;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   02-NOV-2010, entry version 120.
DE   RecName: Full=Inhibitor of nuclear factor kappa-B kinase subunit alpha;
DE            Short=I-kappa-B kinase alpha;
DE            Short=IKK-A;
DE            Short=IKK-alpha;
DE            Short=IkBKA;
DE            Short=IkappaB kinase;
DE            EC=2.7.11.10;
DE   AltName: Full=Conserved helix-loop-helix ubiquitous kinase;
DE   AltName: Full=I-kappa-B kinase 1;
DE            Short=IKK1;
DE   AltName: Full=Nuclear factor NF-kappa-B inhibitor kinase alpha;
DE            Short=NFKBIKA;
DE   AltName: Full=Transcription factor 16;
DE            Short=TCF-16;
GN   Name=CHUK; Synonyms=IKKA, TCF16;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND MUTAGENESIS OF LYS-44.
RC   TISSUE=T-cell;
RX   MEDLINE=97386461; PubMed=9244310; DOI=10.1016/S0092-8674(00)80344-X;
RA   Regnier C.H., Song H.Y., Gao X., Goeddel D.V., Cao Z., Rothe M.;
RT   "Identification and characterization of an IkappaB kinase.";
RL   Cell 90:373-383(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   MEDLINE=97394468; PubMed=9252186; DOI=10.1038/41493;
RA   DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M.;
RT   "A cytokine-responsive IkappaB kinase that activates the transcription
RT   factor NF-kappaB.";
RL   Nature 388:548-554(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, VARIANT VAL-268,
RP   AND MUTAGENESIS OF LYS-44 AND SER-176.
RC   TISSUE=Cervix carcinoma;
RX   MEDLINE=98008813; PubMed=9346484; DOI=10.1126/science.278.5339.860;
RA   Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L.,
RA   Li J.W., Young D.B., Barbosa M., Mann M., Manning A., Rao A.;
RT   "IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-
RT   kappaB activation.";
RL   Science 278:860-866(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RX   MEDLINE=99032998; PubMed=9813230; DOI=10.1016/S0378-1119(98)00462-4;
RA   Hu M.C.-T., Wang Y.-P.;
RT   "IkappaB kinase-alpha and -beta genes are coexpressed in adult and
RT   embryonic tissues but localized to different human chromosomes.";
RL   Gene 222:31-40(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT VAL-268.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-268.
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 32-745.
RC   TISSUE=Cervix carcinoma;
RX   MEDLINE=96258427; PubMed=8777433;
RA   Connelly M.A., Marcu K.B.;
RT   "CHUK, a new member of the helix-loop-helix and leucine zipper
RT   families of interacting proteins, contains a serine-threonine kinase
RT   catalytic domain.";
RL   Cell. Mol. Biol. Res. 41:537-549(1995).
RN   [8]
RP   PROTEIN SEQUENCE OF 169-181, INACTIVATION BY YERSINIA YOPJ,
RP   ACETYLATION AT THR-179, AND MASS SPECTROMETRY.
RX   PubMed=17116858; DOI=10.1073/pnas.0608995103;
RA   Mittal R., Peak-Chew S.Y., McMahon H.T.;
RT   "Acetylation of MEK2 and I kappa B kinase (IKK) activation loop
RT   residues by YopJ inhibits signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:18574-18579(2006).
RN   [9]
RP   IDENTIFICATION IN A COMPLEX WITH IKBKB; NFKBIA; RELA; IKBKAP AND
RP   MAP3K14.
RX   MEDLINE=98421679; PubMed=9751059; DOI=10.1038/26254;
RA   Cohen L., Henzel W.J., Baeuerle P.A.;
RT   "IKAP is a scaffold protein of the IkappaB kinase complex.";
RL   Nature 395:292-296(1998).
RN   [10]
RP   PHOSPHORYLATION AT SER-176, AND MUTAGENESIS OF SER-176; THR-179 AND
RP   SER-180.
RX   MEDLINE=98188283; PubMed=9520446; DOI=10.1073/pnas.95.7.3792;
RA   Ling L., Cao Z., Goeddel D.V.;
RT   "NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of
RT   Ser-176.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:3792-3797(1998).
RN   [11]
RP   PHOSPHORYLATION AT THR-23, AND MUTAGENESIS OF THR-23.
RX   MEDLINE=99413720; PubMed=10485710; DOI=10.1038/43466;
RA   Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M.,
RA   Donner D.B.;
RT   "NF-kappaB activation by tumour necrosis factor requires the Akt
RT   serine-threonine kinase.";
RL   Nature 401:82-85(1999).
RN   [12]
RP   IKKA-IKKB BINDING.
RX   MEDLINE=99212141; PubMed=10195894; DOI=10.1126/science.284.5412.309;
RA   Delhase M., Hayakawa M., Chen Y., Karin M.;
RT   "Positive and negative regulation of IkappaB kinase activity through
RT   IKKbeta subunit phosphorylation.";
RL   Science 284:309-313(1999).
RN   [13]
RP   IKK PHOSPHORYLATION.
RX   MEDLINE=99038238; PubMed=9819420;
RA   Nemoto S., DiDonato J.A., Lin A.;
RT   "Coordinate regulation of IkappaB kinases by mitogen-activated protein
RT   kinase kinase kinase 1 and NF-kappaB-inducing kinase.";
RL   Mol. Cell. Biol. 18:7336-7343(1998).
RN   [14]
RP   REVIEW.
RX   MEDLINE=20178139; PubMed=10712233;
RA   Jobin C., Sartor R.B.;
RT   "The I kappa B/NF-kappa B system: a key determinant of mucosal
RT   inflammation and protection.";
RL   Am. J. Physiol. 278:C451-C462(2000).
RN   [15]
RP   SUBUNIT OF A COMPLEX CONTAINING CREBBP; NCOA2; NCOA3; IKKB AND IKBKG.
RX   MEDLINE=21968797; PubMed=11971985;
RX   DOI=10.1128/MCB.22.10.3549-3561.2002;
RA   Wu R.-C., Qin J., Hashimoto Y., Wong J., Xu J., Tsai S.Y., Tsai M.-J.,
RA   O'Malley B.W.;
RT   "Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator
RT   activity by I kappa B kinase.";
RL   Mol. Cell. Biol. 22:3549-3561(2002).
RN   [16]
RP   COMPOSITION OF THE IKK COMPLEX.
RX   PubMed=12612076; DOI=10.1128/MCB.23.6.2029-2041.2003;
RA   Tegethoff S., Behlke J., Scheidereit C.;
RT   "Tetrameric oligomerization of IkappaB kinase gamma (IKKgamma) is
RT   obligatory for IKK complex activity and NF-kappaB activation.";
RL   Mol. Cell. Biol. 23:2029-2041(2003).
RN   [17]
RP   SUBCELLULAR LOCATION, AND FUNCTION IN PHOSPHORYLATION OF HISTONE H3.
RX   PubMed=12789342; DOI=10.1038/nature01576;
RA   Yamamoto Y., Verma U.N., Prajapati S., Kwak Y.T., Gaynor R.B.;
RT   "Histone H3 phosphorylation by IKK-alpha is critical for cytokine-
RT   induced gene expression.";
RL   Nature 423:655-659(2003).
RN   [18]
RP   INTERACTION WITH NALP2.
RX   PubMed=15456791; DOI=10.1074/jbc.M406741200;
RA   Bruey J.-M., Bruey-Sedano N., Newman R., Chandler S., Stehlik C.,
RA   Reed J.C.;
RT   "PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates
RT   NF-kappaB and caspase-1 activation in macrophages.";
RL   J. Biol. Chem. 279:51897-51907(2004).
RN   [19]
RP   INTERACTION WITH ARRB1 AND ARRB2.
RX   PubMed=15173580; DOI=10.1073/pnas.0402851101;
RA   Witherow D.S., Garrison T.R., Miller W.E., Lefkowitz R.J.;
RT   "beta-Arrestin inhibits NF-kappaB activity by means of its interaction
RT   with the NF-kappaB inhibitor IkappaBalpha.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:8603-8607(2004).
RN   [20]
RP   INTERACTION WITH MAVS.
RX   PubMed=16177806; DOI=10.1038/nature04193;
RA   Meylan E., Curran J., Hofmann K., Moradpour D., Binder M.,
RA   Bartenschlager R., Tschopp J.;
RT   "Cardif is an adaptor protein in the RIG-I antiviral pathway and is
RT   targeted by hepatitis C virus.";
RL   Nature 437:1167-1172(2005).
RN   [21]
RP   FUNCTION, AND INTERACTION WITH NLRC5.
RX   PubMed=20434986; DOI=10.1016/j.cell.2010.03.040;
RA   Cui J., Zhu L., Xia X., Wang H.Y., Legras X., Hong J., Ji J., Shen P.,
RA   Zheng S., Chen Z.J., Wang R.F.;
RT   "NLRC5 negatively regulates the NF-kappaB and type I interferon
RT   signaling pathways.";
RL   Cell 141:483-496(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [23]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-126; ALA-155 AND VAL-268.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Acts as part of the IKK complex in the conventional
CC       pathway of NF-kappa-B activation and phosphorylates inhibitors of
CC       NF-kappa-B thus leading to the dissociation of the inhibitor/NF-
CC       kappa-B complex and ultimately the degradation of the inhibitor.
CC       As part of the non-canonical pathway of NF-kappa-B activation, the
CC       MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100
CC       associated with RelB, inducing its proteolytic processing to
CC       NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. Also
CC       phosphorylates NCOA3. Phosphorylates 'Ser-10' of histone H3 at NF-
CC       kappa-B-regulated promoters during inflammatory responses
CC       triggered by cytokines.
CC   -!- CATALYTIC ACTIVITY: ATP + [I-kappa-B protein] = ADP + [I-kappa-B
CC       phosphoprotein].
CC   -!- ENZYME REGULATION: Activated when phosphorylated and inactivated
CC       when dephosphorylated.
CC   -!- SUBUNIT: Component of the I-kappa-B-kinase (IKK) core complex
CC       consisting of CHUK, IKBKB and IKBKG; probably four alpha/CHUK-
CC       beta/IKBKB dimers are associated with four gamma/IKBKG subunits.
CC       The IKK core complex seems to associate with regulatory or adapter
CC       proteins to form a IKK-signalosome holo-complex. The IKK complex
CC       associates with TERF2IP/RAP1, leading to promote IKK-mediated
CC       phosphorylation of RELA/p65. Part of a complex composed of NCOA2,
CC       NCOA3, CHUK/IKKA, IKBKB, IKBKG and CREBBP. Part of a 70-90 kDa
CC       complex at least consisting of CHUK/IKKA, IKBKB, NFKBIA, RELA,
CC       IKBKAP and MAP3K14. Directly interacts with IKK-gamma/NEMO and
CC       TRPC4AP (By similarity). May interact with TRAF2. Interacts with
CC       NALP2. May interact with MAVS/IPS1. Interacts with ARRB1 and
CC       ARRB2. Interacts with NLRC5; prevents CHUK phosphorylation and
CC       kinase activity.
CC   -!- INTERACTION:
CC       Self; NbExp=1; IntAct=EBI-81249, EBI-81249;
CC       Q13451:FKBP5; NbExp=1; IntAct=EBI-81249, EBI-306914;
CC       O14920:IKBKB; NbExp=3; IntAct=EBI-81249, EBI-81266;
CC       Q9Y6K9:IKBKG; NbExp=3; IntAct=EBI-81249, EBI-81279;
CC       Q99558:MAP3K14; NbExp=2; IntAct=EBI-81249, EBI-358011;
CC       Q7Z434:MAVS; NbExp=1; IntAct=EBI-81249, EBI-995373;
CC       Q9Y6Q9:NCOA3; NbExp=1; IntAct=EBI-81249, EBI-81196;
CC       P25963:NFKBIA; NbExp=3; IntAct=EBI-81249, EBI-307386;
CC       Q04206:RELA; NbExp=1; IntAct=EBI-81249, EBI-73886;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Shuttles between
CC       the cytoplasm and the nucleus.
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- PTM: Phosphorylated by MAP3K14/NIK, AKT and to a lesser extent by
CC       MEKK1, and dephosphorylated by PP2A. Autophosphorylated.
CC   -!- PTM: Acetylation of Thr-179 by Yersinia yopJ prevents
CC       phosphorylation and activation, thus blocking the I-kappa-B
CC       signaling pathway.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. I-kappa-B kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/chuk/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF012890; AAC51662.1; -; mRNA.
DR   EMBL; AF009225; AAC51671.1; -; mRNA.
DR   EMBL; AF080157; AAD08996.1; -; mRNA.
DR   EMBL; AY652653; AAT49098.1; -; Genomic_DNA.
DR   EMBL; AL138921; CAH72401.1; -; Genomic_DNA.
DR   EMBL; U22512; AAC50713.1; -; mRNA.
DR   IPI; IPI00005104; -.
DR   RefSeq; NP_001269.3; -.
DR   UniGene; Hs.198998; -.
DR   PDB; 3BRT; X-ray; 2.25 A; A/C=732-745.
DR   PDBsum; 3BRT; -.
DR   ProteinModelPortal; O15111; -.
DR   SMR; O15111; 20-289, 709-744.
DR   DIP; DIP-27526N; -.
DR   IntAct; O15111; 78.
DR   MINT; MINT-88648; -.
DR   STRING; O15111; -.
DR   PhosphoSite; O15111; -.
DR   PRIDE; O15111; -.
DR   Ensembl; ENST00000370397; ENSP00000359424; ENSG00000213341.
DR   GeneID; 1147; -.
DR   KEGG; hsa:1147; -.
DR   UCSC; uc001kqp.1; human.
DR   CTD; 1147; -.
DR   GeneCards; GC10M101938; -.
DR   H-InvDB; HIX0201495; -.
DR   HGNC; HGNC:1974; CHUK.
DR   HPA; CAB004240; -.
DR   HPA; CAB018564; -.
DR   HPA; HPA001402; -.
DR   MIM; 600664; gene.
DR   PharmGKB; PA26510; -.
DR   eggNOG; prNOG14699; -.
DR   HOGENOM; HBG358635; -.
DR   HOVERGEN; HBG018241; -.
DR   InParanoid; O15111; -.
DR   BRENDA; 2.7.11.10; 247.
DR   Pathway_Interaction_DB; nfkappabalternativepathway; Alternative NF-kappaB pathway.
DR   Pathway_Interaction_DB; bcr_5pathway; BCR signaling pathway.
DR   Pathway_Interaction_DB; nfkappabcanonicalpathway; Canonical NF-kappaB pathway.
DR   Pathway_Interaction_DB; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt.
DR   Pathway_Interaction_DB; faspathway; FAS signaling pathway (CD95).
DR   Pathway_Interaction_DB; fcer1pathway; Fc-epsilon receptor I signaling in mast cells.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; hivnefpathway; HIV-1 Nef: Negative effector of Fas and TNF-alpha.
DR   Pathway_Interaction_DB; il1pathway; IL1-mediated signaling events.
DR   Pathway_Interaction_DB; avb3_opn_pathway; Osteopontin-mediated events.
DR   Pathway_Interaction_DB; p75ntrpathway; p75(NTR)-mediated signaling.
DR   Pathway_Interaction_DB; tcrpathway; TCR signaling in naive CD4+ T cells.
DR   Pathway_Interaction_DB; cd8tcrpathway; TCR signaling in naive CD8+ T cells.
DR   Pathway_Interaction_DB; tnfpathway; TNF receptor signaling pathway.
DR   Pathway_Interaction_DB; trail_pathway; TRAIL signaling pathway.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 4772; -.
DR   ArrayExpress; O15111; -.
DR   Bgee; O15111; -.
DR   CleanEx; HS_CHUK; -.
DR   Genevestigator; O15111; -.
DR   GermOnline; ENSG00000107566; Homo sapiens.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008384; F:IkappaB kinase activity; TAS:ProtInc.
DR   GO; GO:0007252; P:I-kappaB phosphorylation; TAS:ProtInc.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   InterPro; IPR022007; IKKbetaNEMObind.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF12179; IKKbetaNEMObind; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Kinase; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    745       Inhibitor of nuclear factor kappa-B
FT                                kinase subunit alpha.
FT                                /FTId=PRO_0000086011.
FT   DOMAIN       15    302       Protein kinase.
FT   DOMAIN      455    476       Leucine-zipper.
FT   NP_BIND      21     29       ATP (By similarity).
FT   REGION      738    743       NEMO-binding.
FT   ACT_SITE    144    144       Proton acceptor (By similarity).
FT   BINDING      44     44       ATP (By similarity).
FT   MOD_RES      23     23       Phosphothreonine; by PKB/AKT1.
FT   MOD_RES     176    176       Phosphoserine; by MAP3K14.
FT   MOD_RES     179    179       O-acetylthreonine; by Yersinia yopJ.
FT   VARIANT     126    126       S -> C (in dbSNP:rs34427437).
FT                                /FTId=VAR_040565.
FT   VARIANT     155    155       V -> A (in dbSNP:rs2230803).
FT                                /FTId=VAR_040566.
FT   VARIANT     268    268       I -> V (in dbSNP:rs2230804).
FT                                /FTId=VAR_021359.
FT   MUTAGEN      23     23       T->A: Loss of phosphorylation and
FT                                decrease of kinase activity.
FT   MUTAGEN      44     44       K->A: Loss of kinase activity.
FT   MUTAGEN      44     44       K->M: Loss of autophosphorylation.
FT   MUTAGEN     176    176       S->A: Loss of phosphorylation and of
FT                                activity.
FT   MUTAGEN     176    176       S->E: Full activation.
FT   MUTAGEN     179    179       T->A: No change in phosphorylation.
FT   MUTAGEN     180    180       S->A: No change in phosphorylation.
FT   CONFLICT    543    543       E -> G (in Ref. 2; AAC51671).
FT   CONFLICT    604    604       L -> R (in Ref. 7; AAC50713).
FT   CONFLICT    679    680       TS -> AY (in Ref. 7; AAC50713).
FT   CONFLICT    684    684       P -> A (in Ref. 3; no nucleotide entry
FT                                and 7; AAC50713).
FT   CONFLICT    686    687       TS -> DL (in Ref. 7; AAC50713).
SQ   SEQUENCE   745 AA;  84654 MW;  7A90B59BC98A56C2 CRC64;
     MERPPGLRPG AGGPWEMRER LGTGGFGNVC LYQHRELDLK IAIKSCRLEL STKNRERWCH
     EIQIMKKLNH ANVVKACDVP EELNILIHDV PLLAMEYCSG GDLRKLLNKP ENCCGLKESQ
     ILSLLSDIGS GIRYLHENKI IHRDLKPENI VLQDVGGKII HKIIDLGYAK DVDQGSLCTS
     FVGTLQYLAP ELFENKPYTA TVDYWSFGTM VFECIAGYRP FLHHLQPFTW HEKIKKKDPK
     CIFACEEMSG EVRFSSHLPQ PNSLCSLIVE PMENWLQLML NWDPQQRGGP VDLTLKQPRC
     FVLMDHILNL KIVHILNMTS AKIISFLLPP DESLHSLQSR IERETGINTG SQELLSETGI
     SLDPRKPASQ CVLDGVRGCD SYMVYLFDKS KTVYEGPFAS RSLSDCVNYI VQDSKIQLPI
     IQLRKVWAEA VHYVSGLKED YSRLFQGQRA AMLSLLRYNA NLTKMKNTLI SASQQLKAKL
     EFFHKSIQLD LERYSEQMTY GISSEKMLKA WKEMEEKAIH YAEVGVIGYL EDQIMSLHAE
     IMELQKSPYG RRQGDLMESL EQRAIDLYKQ LKHRPSDHSY SDSTEMVKII VHTVQSQDRV
     LKELFGHLSK LLGCKQKIID LLPKVEVALS NIKEADNTVM FMQGKRQKEI WHLLKIACTQ
     SSARSLVGSS LEGAVTPQTS AWLPPTSAEH DHSLSCVVTP QDGETSAQMI EENLNCLGHL
     STIIHEANEE QGNSMMNLDW SWLTE
//
